Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for Fortress Biotech Inc in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
OM
Opaleye Management Inc.
|
890.0K | 2.80% | −152.0K (−14.6%) | Q4 '25 | 0.3% | |
|
Shares held by quarter
Peak holding1.1M (Q4'25)
Change over 8 quarters+890.0K
Share of the company2.800%
|
||||||
|
VC
Vanguard Capital Management LLC
|
1.0M | 3.26% | +71.2K (+7.4%) | 2023 | 0.0% | |
|
Shares held by quarter
Peak holding1.0M (Q2'26)
Change over 8 quarters+1.0M
Share of the company3.260%
|
||||||
28 more super investors behind a free account
See every manager holding Fortress Biotech Inc, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$2.14M | 697.8K | 2.19% | 0.00% | June 30, 2026 |
|
VE
Vanguard Index Funds
|
$856K | 279.9K | 0.88% | 0.00% | June 30, 2026 |
14 more funds behind a free account
See every fund holding Fortress Biotech Inc and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
LA
Lindsay A. Rosenwald, M.D.
5%+ holder
13D · 20.7%
|
6.9M | 21.76% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
WM
Weiss Michael S
Insider
|
822.8K | 2.59% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company2.590%
|
||||||
6 more holders behind a free account
See every insider and 5%+ holder of Fortress Biotech Inc.
Sign up freeLoading...